Company Name¡GJanssen-Cilag Taiwan, a division of Johnson & Johnson Taiwain Ltd.
Address¡G8th Floor, No. 319, Sec. 2 Tunhwa S. Road, Taipei 106, Taiwan,
R.O.C.
Telephone¡G(02)2732-6611
Fax¡G(02)2735-0838
E-mail ¡Gjanssen@mail.sysnet.net.tw
Website¡Gwww.jnj.com
General Manager¡GMr. Sang Jin Kim
Established in¡GJan. 1st, 1987
Working Capital¡GNT$140,000,000
No. of Employees¡G132 |
 |
¡@ Janssen-Cilag Taiwan
(JCT), a division of Johnson & Johnson Taiwan Ltd., was founded in 1987 and since then JCT has expanded through various marketing channels. With the high efficiency in its headquarter's R& D as a rapport, JCT's sales grow rapidly within a short period of years. Its unique managing style further sets up as a successful model of localization among foreign-investment companies. In the aspect of marketing programs, JCT has actively launched innovative new drugs and develop ethical drugs. JCT further educates the public to learn self-treatment and relevant concepts to minor diseases. As for quality, not only would the products meet the rigid governmental regulations, but JCT is also devoted in customer services. In fact, JCT was been recognized and awarded with "Standards of Quality" which is based on the standards of US National Quality. With respect to management, JCT focuses in people development and the spirit of teamwork. JCT encourages its employees to challenge the status quo in accomplish both company ultimate objectives and personal career development.
Business Scope
¡@The main business of JCT includes introducing new drugs developed by its R&D Department, market high quality products, arrange activities, like advertisement, education, promotion and distribution. JCT's marketing activities fully correspond with the needs of local medical environment. Through the approaches of clinical studies, congresses and symposiums, exchange of opinions and gaining of knowledge can be enhanced. With the implementation of national health insurance scheme, JCT hopes to expedite launching new and cost-effective drugs in order to be aligned with the local government's policies to elevate service level of medical insurance and to maintain reasonable medical expenditure..
Major products
¡@¡·Durogesic- Transdermal Fentanyl patch provide 48~72-hour analgesic effect in moderate to severe chronic pain.
¡@¡·EPREX- It is a haematopoietic agent and the first generic recombinant human erythropoietin, which can be used to treat renal disease associated anemia or for those patients needed blood transfusion. In addition, EPREX can be used for the treatment of anamia in adult cancer patients receiving chemotherapy.
¡@¡·Imodium- It's indicated for the symptomatic control of acute and chronic diarrhea. In patients with an ileostomy it can be used to reduce the number and volume of stools and to harden their consistency.
¡@¡·Nizoral shampoo- It's a clinically proven ingredient for treatment of flakes and itching associated with dandruff.
¡@¡·Prepulsid- The first prokinetic agent acting in myenteric plexus to treat dyspepsia and
GORD.
¡@¡·Risperdal- Atypical antipsychotic, indicated for the treatment of a broad range of patients with schizophrenia, in which positive symptoms and/or negative symptoms are prominent. Risperdal alleviates affective symptoms associated with schizophrenia. Risperdal is also effective in maintaining the clinical improvement during continuation therapy in patients who have shown an initial treatment response and well tolerated.
¡@¡·Sibelium- Vasodilating agent. Prophylaxis of classic (with aura) or common (without aura)
migrain, symptomatic treatment of vestibular vertigo, due to a diagnosed functional disorder of the vestibular system.
¡@¡·Sporanox- it is a new generation of broad-spectrum azole antifungal. It can be used in treatment for systemic fungal infection,
onychomycosis, and other superficial mycosis like Tinea Pedis, Tinea
Corporis, Tinea Versicolor, and vaginal candidosis.
¡@¡·Tinset- the first broad-spectrum anti-allergics, it is a mast cell stabilizer, and has dual actions in treating and preventing chronic allergic conditions like
urticaris, allergic rhinitis, etc. Can also be used in childhood asthma prevention.
¡@¡·Topamax- Anticonvulsants with multi-mechanism for Epilepsy disease management. Therapeutic Indications: Adjunctive therapy for adults and children with partial onset seizures, seizures associated with
Lennox-Gastaut syndrome, and generalized tonic-clonic seizures.
|
